Panacea Biotec Share Price
Panacea Biotec Share Price Today
As of 5 Jul 2026, Panacea Biotec share price is ₹551.20. The stock opened at ₹554.95, compared to its previous close of ₹548.25. During today's trading session, Panacea Biotec share price moved in the range of ₹536.00 to ₹556.15, with an average price of ₹546.08 for the day. Looking at its last 52-week, the stock has touched a low of ₹292.40 and a high of ₹647.00. On the performance front, Panacea Biotec share price has increased by 45.11% over the last six months and is up 31.82% on a year-on-year basis.
Panacea Biotec Returns Calculator
Panacea Biotec Shareholder Returns
Panacea Biotec Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Panacea Biotec Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹559.09 | ₹559.17 | ₹459.95 | ₹661.23 |
| Other Income | ₹20.66 | ₹25.80 | ₹51.66 | ₹10.97 |
| Total Revenue | ₹579.75 | ₹584.96 | ₹511.61 | ₹672.20 |
| Total Expenses | ₹623.70 | ₹619.52 | ₹601.47 | ₹899.05 |
| Profit Before Tax | -₹7.95 | ₹1.48 | ₹12.81 | ₹1,449.36 |
| Tax | ₹0.77 | ₹2.98 | ₹46.55 | ₹371.02 |
| Profit After Tax | -₹8.72 | -₹1.51 | -₹33.75 | ₹1,078.33 |
| EPS - Basic | -₹1.37 | -₹0.19 | -₹5.43 | ₹176.05 |
| EPS - Diluted | -₹1.37 | -₹0.19 | -₹5.43 | ₹176.05 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹7.95 | ₹1.48 | ₹12.81 | ₹1,449.36 |
| Income before WC changes | -₹17.82 | -₹7.28 | -₹83.06 | -₹5.61 |
| Change in Assets | -₹101.58 | -₹0.85 | -₹13.27 | -₹73.14 |
| Change in Liabilities | ₹93.00 | ₹10.54 | -₹323.65 | ₹374.00 |
| Change in WC | -₹8.58 | ₹9.69 | -₹336.91 | ₹300.86 |
| Cash flow from Operations | -₹27.37 | -₹0.10 | -₹422.45 | -₹108.45 |
| Cash flow from Investing | ₹64.98 | ₹10.23 | ₹430.33 | ₹1,282.57 |
| Cash flow from Financing | -₹2.66 | -₹2.81 | -₹18.37 | -₹1,175.85 |
| Total Cash Flow | ₹34.95 | ₹7.32 | -₹10.49 | -₹1.73 |
| Cash (Start of the year) | ₹47.17 | ₹39.85 | ₹50.35 | ₹52.08 |
| Cash (End of the year) | ₹82.13 | ₹47.17 | ₹39.85 | ₹50.34 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹744.57 | ₹755.49 | ₹708.85 | ₹808.31 |
| Current Assets | ₹545.18 | ₹485.18 | ₹562.32 | ₹950.56 |
| Total Assets | ₹1,289.75 | ₹1,240.67 | ₹1,271.17 | ₹1,758.87 |
| Current Liabilities | ₹366.99 | ₹308.83 | ₹329.73 | ₹776.37 |
| Net Current Asset | ₹178.19 | ₹176.35 | ₹232.59 | ₹174.19 |
| Non-Current Liabilities | ₹92.14 | ₹93.61 | ₹101.32 | ₹108.85 |
| Equity Capital | ₹830.62 | ₹838.23 | ₹840.11 | ₹873.66 |
| Total Equity & Liabilities | ₹1,289.75 | ₹1,240.67 | ₹1,271.17 | ₹1,758.87 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹309.86 | ₹359.60 | ₹257.07 | ₹235.50 |
| Other Income | ₹16.62 | ₹24.91 | ₹34.44 | ₹12.57 |
| Total Revenue | ₹326.47 | ₹384.51 | ₹291.50 | ₹248.07 |
| Total Expenses | ₹352.53 | ₹380.31 | ₹354.25 | ₹341.65 |
| Profit Before Tax | -₹26.06 | ₹4.21 | -₹62.75 | -₹93.58 |
| Tax | -₹10.83 | ₹0.66 | ₹24.79 | ₹0.00 |
| Profit After Tax | -₹15.23 | ₹3.55 | -₹87.54 | -₹93.58 |
| EPS - Basic | -₹2.49 | ₹0.58 | -₹14.29 | -₹15.28 |
| EPS - Diluted | -₹2.49 | ₹0.58 | -₹14.29 | -₹15.28 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹26.06 | ₹4.21 | -₹62.75 | -₹93.58 |
| Income before WC changes | ₹3.87 | ₹30.95 | -₹52.32 | -₹57.60 |
| Change in Assets | -₹50.40 | ₹0.78 | ₹5.19 | -₹38.97 |
| Change in Liabilities | ₹51.58 | ₹3.22 | ₹37.48 | ₹44.70 |
| Change in WC | ₹1.18 | ₹4.00 | ₹42.67 | ₹5.73 |
| Cash flow from Operations | ₹3.94 | ₹33.07 | -₹10.74 | -₹52.69 |
| Cash flow from Investing | -₹60.60 | -₹46.80 | ₹2.41 | ₹39.54 |
| Cash flow from Financing | ₹90.07 | ₹12.82 | ₹9.01 | ₹9.83 |
| Total Cash Flow | ₹33.41 | -₹0.91 | ₹0.67 | -₹3.32 |
| Cash (Start of the year) | ₹5.09 | ₹6.01 | ₹5.33 | ₹8.66 |
| Cash (End of the year) | ₹38.50 | ₹5.09 | ₹6.01 | ₹5.33 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹575.74 | ₹570.30 | ₹524.77 | ₹513.01 |
| Current Assets | ₹293.73 | ₹183.49 | ₹199.13 | ₹248.83 |
| Total Assets | ₹869.47 | ₹753.79 | ₹723.90 | ₹761.83 |
| Current Liabilities | ₹351.40 | ₹249.14 | ₹250.85 | ₹246.76 |
| Net Current Asset | -₹57.67 | -₹65.65 | -₹51.72 | ₹2.07 |
| Non-Current Liabilities | ₹204.10 | ₹175.51 | ₹147.40 | ₹99.98 |
| Equity Capital | ₹313.97 | ₹329.14 | ₹325.65 | ₹415.09 |
| Total Equity & Liabilities | ₹869.47 | ₹753.79 | ₹723.90 | ₹761.83 |
About Panacea Biotec
Panacea Biotec Limited is an India-based pharmaceutical and biotechnology company with research, manufacturing and marketing capabilities. The Company is engaged in the business of research, development, manufacture and marketing of branded vaccines, pharmaceutical formulations, nutraceuticals and food and nutrition products in India and international markets. Its segments include vaccines and formulations. It has specialized in the development of fully liquid combination vaccines that can be stored at 2-8 degree Celsius temperature. Its vaccine portfolio includes EasySix (DTwP-Hib-HepB-IPV), EasyFive-TITM (DTwP-Hib-HepB), EasyFour-TI (DTwP-Hib), EasyFourPol (DTwP-IPV) and Bivalent oral polio vaccine (type-1 and type-3). Its pipeline vaccines include NucoVac 11, DengiALL and Td (tetanus and diphtheria - reduced). Its pharmaceutical formulation products include Sitcom Tablets and Sitcom Cream. Its nutrition product brand names include ChilRunfull, ChilRun 7+ and ChilRun NoSucrose.
Panacea Biotec Financial Highlights
- Revenue: Panacea Biotec reported revenue of ₹656.67 crore in FY26 vs ₹579.75 crore in FY25. It showed an increase of 13.27% on a yearly basis.
- Operating Profit: Panacea Biotec reported an operating loss of ₹7.37 crore in FY26 vs ₹7.95 crore in FY25. It showed an increase of 7.30% on a year-on-year basis.
- Net Profit: Panacea Biotec reported a net loss of ₹7.16 crore in FY26 vs ₹8.72 crore in FY25. It showed an increase of 17.89% on a yearly basis.
Panacea Biotec Quarterly Result Highlights
- Panacea Biotec reported revenue of ₹169.30 crore in Mar 2026, compared with ₹167.47 crore in Dec 2025, representing an increase of 1.09% on a quarter-on-quarter (QoQ) basis.
- Panacea Biotec reported an operating loss of ₹1.25 crore in Mar 2026, compared with ₹6.49 crore in Dec 2025, representing a decrease of 119.26% on a quarter-on-quarter (QoQ) basis.
- Panacea Biotec reported a loss of ₹1.00 crore in Mar 2026, compared with ₹3.89 crore in Dec 2025, reflecting a decrease of 125.71% on a QoQ basis.
- The earnings per share (EPS) of Panacea Biotec stood at ₹1.37 during Mar 2026.
Similar Stocks
FAQs on Panacea Biotec Share Price
What is Panacea Biotec share price today?
Panacea Biotec share price is ₹551.20 as on 03 Jul, 2026, 15:46 IST.
How has the Panacea Biotec share price performed in the past?
In the last 1 year, Panacea Biotec delivered a return of 31.82%. The Panacea Biotec share price hit a high of ₹647.00 and low of ₹292.40.
How much is the Mutual Fund shareholding in Panacea Biotec shares?
The Mutual Fund Shareholding in Panacea Biotec was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Panacea Biotec shares ?
The 52-week high and low of Panacea Biotec share is ₹647.00 and ₹292.40 as of 03 Jul, 2026.
What is the market cap of Panacea Biotec?
The market capitalisation of Panacea Biotec is ₹3,352.56 Crores as on 03 Jul, 2026.
What are the stock symbols of Panacea Biotec?
The stock symbol of Panacea Biotec is PANACEABIO on the NSE, 531349 on the BSE, and the ISIN is INE922B01023.
What was yesterday's closing price of Panacea Biotec shares ?
Panacea Biotec shares closed yesterday at ₹548.25 on NSE & ₹547.35 on BSE
How to buy Panacea Biotec shares?
To buy Panacea Biotec shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Panacea Biotec shares on Holidays?
No, shares of Panacea Biotec or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Panacea Biotec shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Panacea Biotec?
The PE and PB ratio of Panacea Biotec is -467.82 and 4.02 respectively, as on 03 Jul, 2026, 15:46 IST.